Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Regeneron Pharmaceuticals Inc (NASDAQ:REGN)

419.10
Delayed Data
As of Sep 28
 -2.35 / -0.56%
Today’s Change
329.09
Today|||52-Week Range
592.59
-22.80%
Year-to-Date
Biotech Stock Roundup: Amgen's Kyprolis Disappoints, Array Up on Cancer Data
Sep 28 / Zacks.com - Paid Partner Content
3 Growth Stocks You Can Buy Cheap Right Now
Sep 26 / MotleyFool.com - Paid Partner Content
3 Top Dividend Stocks Selling for a Discount This Fall
Sep 28 / MotleyFool.com - Paid Partner Content
5 Stocks with Impressive Sales Growth to Bet On
Sep 26 / Zacks.com - Paid Partner Content
3 Critical FDA Decisions You Can't Afford to Miss
Sep 27 / MotleyFool.com - Paid Partner Content
Regeneron, Teva Collaborate to Develop Chronic Pain Drug
Sep 21 / Zacks.com - Paid Partner Content
Zacks.com featured highlights: Regeneron Pharmaceuticals, Nordstrom, Intel, Nu Skin E...
Sep 27 / Zacks.com - Paid Partner Content
Biotech Stock Roundup: Tobira Soars on Acquisition Deal, FDA Says Yes to Sarepta DMD ...
Sep 21 / Zacks.com - Paid Partner Content
Regeneron, Sanofi Skin Disease Drug Under Priority Review
Sep 26 / Zacks.com - Paid Partner Content